Scarica l'app Stockscreener
4.16
5.45%
-0.24
Dopo l'orario di chiusura:
4.10
-0.06
-1.44%
Precedente Chiudi:
$4.40
Aprire:
$4.4
Volume 24 ore:
218.99K
Relative Volume:
0.10
Capitalizzazione di mercato:
$7.05M
Reddito:
$4.79M
Utile/perdita netta:
$-13.42M
Rapporto P/E:
-1.5639
EPS:
-2.66
Flusso di cassa netto:
$-10.30M
1 W Prestazione:
-20.46%
1M Prestazione:
+124.26%
6M Prestazione:
+36.39%
1 anno Prestazione:
-50.89%
Intervallo 1D:
$4.10
$4.67
Intervallo di 1 settimana:
$4.10
$5.2816
Portata 52W:
$1.61
$10.45
Qualigen Therapeutics Inc Stock (QLGN) Company Profile
Nome
Qualigen Therapeutics Inc
Settore
Industria
Telefono
(760) 918-9165
Indirizzo
2042 CORTE DEL NOGAL, CALIFORNIA
Confronta QLGN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
QLGN
Qualigen Therapeutics Inc
|
4.16 | 8.95M | 4.79M | -13.42M | -10.30M | -2.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Qualigen Therapeutics Inc Borsa (QLGN) Ultime notizie
Qualigen Therapeutics, Inc. Launches C10 Cryptocurrency Asset Treasury Purchases Amid Crypto Market Volatility - Quiver Quantitative
Qualigen Therapeutics Announces the Official Launch of C10 Cryptocurrency Asset Treasury (DAT) Purchases: Why Is This Pullback the Golden Moment CXC10 Has Been Waiting For? - Stock Titan
Qualigen Therapeutics Announces the Official Launch of C10 Cryptocurrency Asset Treasury (DAT) Purchases: Why Is This Pullback the Golden Moment CXC10 Has Been Waiting For? - GlobeNewswire Inc.
What machine learning models say about Qualigen Therapeutics Inc.2025 EndofYear Setup & Accurate Entry and Exit Point Alerts - newser.com
Can technical indicators confirm Qualigen Therapeutics Inc.’s reversalMarket Rally & Consistent Growth Equity Picks - newser.com
How to integrate Qualigen Therapeutics Inc. into portfolio analysis toolsJuly 2025 PreEarnings & Scalable Portfolio Growth Ideas - newser.com
Why Qualigen Therapeutics Inc. is moving todayTrade Volume Report & Scalable Portfolio Growth Methods - newser.com
Multi asset correlation models including Qualigen Therapeutics Inc.Quarterly Portfolio Report & Stepwise Trade Signal Implementation - newser.com
What technical models suggest about Qualigen Therapeutics Inc.’s comeback - newser.com
Can machine learning forecast Qualigen Therapeutics Inc. recoveryJuly 2025 Sector Moves & Consistent Profit Trade Alerts - newser.com
How to read the order book for Qualigen Therapeutics Inc.Trade Exit Summary & Detailed Earnings Play Alerts - newser.com
How to monitor Qualigen Therapeutics Inc. with trend dashboardsJuly 2025 Patterns & Weekly Top Gainers Trade List - newser.com
Qualigen Therapeutics, Inc. Announces Leadership and Governance Changes to Support Strategic Growth - Quiver Quantitative
Qualigen Therapeutics appoints Jerry Wang as co-CEO, Koti Meka as CFO - MarketScreener
Qualigen Therapeutics (NASDAQ: QLGN) Announces Executives, - GlobeNewswire
Co-CEO Jerry Wang & CFO Koti Meka join Qualigen; Board adds 3 directors and auditor switches to MGO for FY2025 - Stock Titan
How to recover losses in Qualigen Therapeutics Inc. stockJuly 2025 Big Picture & Trade Opportunity Analysis - newser.com
Will Qualigen Therapeutics Inc. stock maintain growth storyJuly 2025 News Drivers & Proven Capital Preservation Tips - newser.com
Will Qualigen Therapeutics Inc. (7R90) stock recover faster than industrySwing Trade & AI Based Buy/Sell Signal Reports - newser.com
Qualigen Therapeutics Secures $41M for Crypto Transformation - TipRanks
Will Qualigen Therapeutics Inc. (7R90) stock hit analyst forecastsWeekly Investment Summary & Daily Volume Surge Trade Alerts - newser.com
Faraday Future Announces Closing of Strategic $41 Million Investment in Qualigen Therapeutics (NASDAQ: QLGN) to Accelerate its Dual-Flywheel & Dual-Bridge Eco Strategy - ADVFN
Univest Securities, LLC Announces Closing of $41 Million Strategic Investment in Client Qualigen Therapeutics (NASDAQ: QLGN) from Client Faraday Future (NASDAQ: FFAI) - ADVFN
Faraday Future Announces Strategic $41 Million Investment in Qualigen Therapeutics, Inc. (NASDAQ: QLGN) for Crypto Business Through PIPE Transaction - ADVFN
Qualigen Therapeutics Announces Successful Closing of $41 Million PIPE Financing Led by Faraday Future, Accelerating New Business Transformation into Crypto - ADVFN
Faraday Future Announced a Total Strategic Investment of $41 million in Qualigen Therapeutics, Inc. (NASDAQ: QLGN) During its Annual 919 Event, for its Crypto Business Focusing on Three Growth Engines - ADVFN
Faraday Future’s $41M Investment in Qualigen for Web3 - MSN
Qualigen to invest in NanoSynex, stock tumbles 21% - MSN
Faraday Future completes $41 million investment in Qualigen By Investing.com - Investing.com Nigeria
Faraday Future completes $41 million investment in Qualigen Therapeutics By Investing.com - Investing.com Nigeria
Qualigen Therapeutics, Inc. announced that it has received $41 million in funding from Faraday Future Intelligent Electric Inc., Sequoia Capital, IDgo, Inc and other investor. - MarketScreener
Univest Securities announces closing of $41 million strategic investment in client Qualigen Therapeutics - MarketScreener
Univest Securities, LLC Announces Closing of $41 Million - GlobeNewswire
Univest Securities, LLC Announces Closing of $41 Million Strategic Investment in Client Qualigen Therapeutics (NASDAQ: QLGN) from Client Faraday Future (NASDAQ - MarketScreener
Qualigen Therapeutics, Inc. Appoints Jerry Wang as Co-CEO - MarketScreener
Qualigen Therapeutics, Inc. Appoints Koti Meka as CFO - MarketScreener
Faraday Future Announces Closing of Strategic $41 Million Investment in Qualigen Therapeutics to Accelerate its Dual-Flywheel & Dual-Bridge Eco Strategy - Investing News Network
Faraday Future Announces Closing of Strategic $41 Million - GlobeNewswire
Faraday Future Closes $41 Million Investment in Qualigen Therapeutics - 富途牛牛
FF Completes Strategic Investment in Nasdaq-listed QLGN - 富途牛牛
Qualigen Therapeutics secures $41 million in PIPE financing By Investing.com - Investing.com Australia
Qualigen Therapeutics secures $41 million in PIPE financing - Investing.com India
Qualigen Therapeutics stock soars after closing $41M PIPE financing By Investing.com - Investing.com Canada
Qualigen Therapeutics Inc Azioni (QLGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):